Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,54 USD | -3,81% | -15,77% | -41,72% |
Omzet 2024 * | 2,8 mln. 2,63 mln. | Omzet 2025 * | 32,08 mln. 30,11 mln. | Marktkapitalisatie | 120 mln. 113 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -125 mln. -117 mln. | Nettowinst (verlies) 2025 * | -120 mln. -113 mln. | EV/omzet 2024 * | 42,9 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 3,74 x |
K/w-verhouding 2024 * |
-1,23
x | K/w-verhouding 2025 * |
-1,36
x | Werknemers | 68 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,92% |
Recentste transcriptie over Syros Pharmaceuticals, Inc.
1 dag | -3,81% | ||
1 week | -15,77% | ||
Lopende maand | -15,14% | ||
1 maand | -27,13% | ||
3 maanden | -29,72% | ||
6 maanden | +113,15% | ||
Lopend jaar | -41,72% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Conley Chee
CEO | Chief Executive Officer | 54 | 27-09-21 |
Nancy Simonian
CEO | Chief Executive Officer | 63 | 01-11-12 |
Jason Haas
DFI | Director of Finance/CFO | 56 | 12-10-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Srini Akkaraju
BRD | Director/Board Member | 56 | 12-06-17 |
Tim Tyson
BRD | Director/Board Member | 71 | 16-09-22 |
Marsha Fanucci
BRD | Director/Board Member | 70 | 19-10-15 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 4,54 | -3,81% | 169 157 |
18-04-24 | 4,72 | -7,63% | 119 453 |
17-04-24 | 5,11 | -8,09% | 126 079 |
16-04-24 | 5,56 | +3,93% | 287 406 |
15-04-24 | 5,35 | -0,74% | 148 071 |
uitgestelde koers Nasdaq, 19 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-41,72% | 125 mln. | |
-1,42% | 41,35 mld. | |
+42,15% | 40,38 mld. | |
+1,97% | 39,05 mld. | |
-14,19% | 26,67 mld. | |
+1,82% | 24,07 mld. | |
-24,55% | 18,36 mld. | |
-4,07% | 11,68 mld. | |
+21,36% | 11,6 mld. | |
+8,20% | 11,15 mld. |